|
| Exchange Disseminated Time | Natco Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on August 12, 2014, inter alia, to consider the unaudited financial Results for the quarter ended June 30, 2014, convening of 31st Annual General Meeting and related matters etc.
Further, note that Trading Window for dealing in the securities of the Company will be closed from July 31, 2014 to August 14, 2014 (both days inclusive). Trading window will be opened from August 18, 2014. |
|
|